Advocating Timely Access to New Therapies - Lymphoma Canada

Lymphoma Canada24 Jul, 2026Health

Lymphoma Canada advocates for timely and equitable access to novel lymphoma therapies, aiming to ensure all Canadians receive the best quality healthcare. Every Canadian deserves the opportunity to receive the best quality healthcare, including local access to all Health Canada approved lymphoma therapies with minimal delay. Currently, there is a disparity in available treatments depending on which province or territory a lymphoma patient resides in. These inequities include but are not limited to long delays in accessing approved treatments, financial challenges in affording therapy not funded in a patient’s home province, thereby requiring travel for treatment, and lack of support network when receiving treatment.

CAR-T Therapy for Non-Hodgkin Lymphoma

Lymphoma Canada30 Apr, 2025Health

Chimeric Antigen Receptor T cell therapy, or CAR-T therapy, is a type of immunotherapy that modifies a patient’s T-cells to better detect and destroy lymphoma. A part of the body’s immune system, T cells are a type of white blood cell that attacks virus-infected cells, foreign cells and cancer cells. CAR-T therapy enhances the effectiveness of T cells.

Recent Profiles

BIGBUNNY

Bigbunny

View Profile

thuy adams

Thuy Adams

View Profile

Thảo Nhi Lê

Thảo Nhi Lê

View Profile

Wopslot Resmi slot777

Wopslot Resmi Slot777

View Profile

Wopslot Situs Slot Gacor

Wopslot Situs Slot Gacor

View Profile

GOGUnlocked

Gogunlocked

View Profile

Quốc King

Quốc King

View Profile

Zowin ro

Zowin Ro

View Profile

Ea88k vip

Ea88k Vip

View Profile